Dudediligence.

Cumberland Pharmaceuticals Inc

CPIXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$9.1MSep ’24$10.4MDec ’24$11.7MMar ’25$10.8MJun ’25$8.3MSep ’25$13.7MDec ’25$9.1MMar ’26$8.8MJun ’26
Net income, by quarter
−$1.5MSep ’24−$1.9MDec ’24$1.3MMar ’25−$740,740Jun ’25−$1.9MSep ’25−$1.4MDec ’25−$3.3MMar ’26−$4.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$36.0M$42.0M$39.6M$37.9M$44.5M
Gross profit$27.2M$32.9M$33.5M$31.3M$37.9M
Operating income−$7.7M−$5.7M−$9.6M−$6.4M−$2.8M
Net income−$3.5M−$5.6M−$6.3M−$6.5M−$2.8M
Operating cash flow$6.3M$8.5M$6.1M−$612,186$4.9M
Free cash flow$6.2M$8.4M$5.8M−$678,647$4.8M
Cash$27.0M$19.8M$18.3M$18.0M$11.4M
Debtnone on filenone on file$0.00$5.1M$0.00
Shares outstanding14.7M14.4M14.1M14.0M15.0M